INS and metabolic dysfunction-associated steatotic liver disease: We examined the abnormal changes in physiological and biochemical indicators, including body weight, hepatic steatosis, insulin sensitivity, glucose metabolism, serum lipid profile, inflammatory response, and antioxidant defense function, which are key indicators of NAFLD development (Cobbina and Akhlaghi, 2017; Bessone et al., 2019).